The Equitability of Universal Vaccine Mandates – A Bioethical Analysis ofCOVID-19 Vaccine by 1 National Cardiothoracic Centre, Korle-Bu, Accra-Ghana2 Department of Neurology, University College Hospital, Ibadan, Nigeria
Article Sidebar
Main Article Content
Abstract
In public health emergencies that warrant mass vaccination, vaccine mandates are
sometimes imposed. There is historical evidence of the effectiveness of vaccination
mandates, but varying strategies in policy implementation. The COVID-19 vaccine
mandate presents an ethical imbroglio that poses these bioethical questions, “Is
there ethical justification for a vaccine mandate?”, and “Whose responsibility is it to
ensure the equitability of a vaccine mandate in a pandemic?” Using ethical principles
and theories, this paper focuses on the health equity of vaccine mandates,
considering both the global and local implications.
Vaccination mandate, in a pandemic, is driven by the need to accelerate the
achievement of public health goals of herd immunity, protecting the most vulnerable
in terms of case fatality and hospitalization rates, protecting the capacity of the acute
health care system, as well as circumventing the economic impact. These mandates
must still be guided by appropriate stakeholder involvement and bioethical
considerations, to assess their validity and equitability, as vaccine mandates may
impose restrictions on the freedoms and rights of an individual. Using COVID-19 as
a case study, we argued the equitability of vaccine mandates based on the WHO
framework of ethical considerations and caveats for mandatory vaccination.
Necessity and proportionality of the vaccine, sufficient evidence of safety, efficacy,
and effectiveness, sufficient supply, and public trust are key during ethical processes
of decision-making.
We conclude that vaccine mandates are more equitable as population-specific mandates, as opposed to global or universal mandates, even in pandemics. This is due to varying geographic, socio-cultural, and economic characteristics. Bioethicists should be actively engaged in discussions on the vaccine mandate, as its equitability is a function of critically analyzing the proposed mandate based on ethical recommendations prior to being issued. Retrospective bioethical analysis is warranted to identify shortfalls and make recommendations for future
decision-making
Downloads
Article Details
Section
References
1. WHO Ethics and COVID-19 Working Group. COVID-19 and mandatory vaccination: Ethical
considerations [Internet]. 2021 [cited 2023 Mar 2]. Available from:
2. Ayoub HH, Mumtaz GR, Seedat S, Makhoul M, Chemaitelly H, Abu-Raddad LJ. Estimates of
global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in
2020. Global Epidemiology. 2021 Nov; 3:100068.
3. AJMC Staff. A Timeline of COVID-19 Vaccine Developments in 2021 [Internet]. AJMC. 2021
[cited 2023 Mar 2]. Available from: https://www.ajmc.com/view/a-timeline-of-covid-19-
vaccine-developments-in-2021
4. Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, Board on Health
Sciences Policy, Board on Population Health and Public Health Practice, Health and
Medicine Division, National Academies of Sciences, Engineering, and Medicine. Framework
for Equitable Allocation of COVID-19 Vaccine [Internet]. Gayle H, Foege W, Brown L, Kahn
B, editors. Washington, D.C.: National Academies Press; 2020 [cited 2023 Mar 2]. Available
from: https://www.nap.edu/catalog/25917
5. Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of
COVID-19 vaccinations. Nat Hum Behav. 2021 May 10;5(7):947–53.
6. Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus
Pandemic (COVID-19). Our World in Data [Internet]. 2020 Mar 5 [cited 2023 Mar 2];
Available from: https://ourworldindata.org/covid-vaccinations
7. WHO. Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update
[Internet]. 2022 [cited 2023 Mar 2]. Available from:
8. Laar A, DeBruin D, Ofori-Asenso R, Laar ME, Redman B, Caplan A. Rationing health and
social goods during pandemics: Guidance for Ghanaian decision makers. Clinical Ethics.
2021 Sep;16(3):165–70.
9. Mello MM, Silverman RD, Omer SB. Ensuring Uptake of Vaccines against SARS-CoV-2. N
Engl J Med. 2020 Oct 1;383(14):1296–9.
10. Hagan K, Forman R, Mossialos E, Ndebele P, Hyder AA, Nasir K. COVID-19 vaccine mandate
for healthcare workers in the United States: a social justice policy. Expert Review of
Vaccines. 2022 Jan 2;21(1):37–45.
11. Karaivanov A, Kim D, Lu SE, Shigeoka H. COVID-19 vaccination mandates and vaccine
uptake. Nat Hum Behav. 2022 Jun 2;6(12):1615–24.
12. Wynia MK, Harter TD, Eberl JT. Why A Universal COVID-19 Vaccine Mandate Is Ethical
Today. Health Affairs Forefront [Internet]. [cited 2023 Mar 2]; Available from:
https://www.healthaffairs.org/do/10.1377/forefront.20211029.682797/full/
13. Prugger C, Spelsberg A, Keil U, Erviti J, Doshi P. Evaluating covid-19 vaccine efficacy and
safety in the post-authorisation phase. BMJ. 2021 Dec 23; e067570.
14. Rubin R. COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough.
JAMA. 2021 Apr 6;325(13):1241.
15. Johnson AG, Amin AB, Ali AR, Hoots B, Cadwell BL, Arora S, et al. COVID-19 Incidence and
Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster
Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April
4–December 25, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132–8.
16. Emanuel EJ, Luna F, Schaefer GO, Tan KC, Wolff J. Enhancing the WHO’s Proposed
Framework for Distributing COVID-19 Vaccines Among Countries. Am J Public Health. 2021
Mar;111(3):371–3.
17. Emanuel EJ, Persad G, Kern A, Buchanan A, Fabre C, Halliday D, et al. An ethical framework
for global vaccine allocation. Science. 2020 Sep 11;369(6509):1309–12.
18. National Academies of Sciences E, Division H and M, Practice B on PH and PH, Policy B on
HS, Coronavirus C on EA of V for the N, Kahn B, et al. Lessons Learned from Other Allocation
Efforts [Internet]. Framework for Equitable Allocation of COVID-19 Vaccine. National
Academies Press (US); 2020 [cited 2023 Mar 2]. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK564090/
19. Barugahare J, Nakwagala FN, Sabakaki EM, Ochieng J, K Sewankambo N. Ethical and human
rights considerations in public health in low and middle-income countries: an assessment
using the case of Uganda’s responses to COVID-19 pandemic. BMC Med Ethics. 2020
Dec;21(1):91.
20. Pilz S, Theiler-Schwetz V, Trummer C, Krause R, Ioannidis JPA. SARS-CoV-2 reinfections:
Overview of efficacy and duration of natural and hybrid immunity. Environmental
Research. 2022 Jun; 209:112911.
21. Morens DM, Folkers GK, Fauci AS. The Concept of Classical Herd Immunity May Not Apply
to COVID-19. The Journal of Infectious Diseases. 2022 Aug 24;226(2):195–8.
22. SeyedAlinaghi S, Mirzapour P, Dadras O, Pashaei Z, Karimi A, MohsseniPour M, et al.
Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a
systematic review. Eur J Med Res. 2021 Jun 8;26(1):51.
23. Wong RSY. COVID-19 vaccines and herd immunity: Perspectives, challenges and
prospects. Malays J Pathol. 2021 Aug;43(2):203–17.
24. Bruce L, Tallman R. Promoting racial equity in COVID-19 resource allocation. J Med Ethics.
2021 Apr;47(4):208–12.
25. Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than
Tuskegee: Understanding Mistrust about Research Participation. Journal of Health Care for
the Poor and Underserved. 2010 Aug;21(3):879–97.
26. Vasquez Reyes M. The Disproportional Impact of COVID-19 on African Americans. Health
Hum Rights. 2020 Dec;22(2):299–307.
27. Laurencin CT. Addressing Justified Vaccine Hesitancy in the Black Community. J Racial and
Ethnic Health Disparities. 2021 Jun;8(3):543–6.
28. Sina-Odunsi AJ. COVID-19 vaccines inequity and hesitancy among African Americans.
Clinical Epidemiology and Global Health. 2021 Oct; 12:100876.
29. AJMC Staff. (2021). A Timeline of COVID-19 Vaccine Developments in 2021.
https://www.ajmc.com/view/a-timeline-of-covid-19-vaccine-developments-in-2021.
Retrieved from https://www.ajmc.com/view/a-timeline-of-covid-19-vaccinedevelopments-in-2021
30. Ayoub, H. H., Mumtaz, G. R., Seedat, S., Makhoul, M., Chemaitelly, H., & Abu-Raddad, L. J.
(2021). Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and
infection mortality rates in 2020. Global Epidemiology, 3, 100068.
31. Barugahare, J., Nakwagala, F. N., Sabakaki, E. M., Ochieng, J., & K Sewankambo, N. (2020).
Ethical and human rights considerations in public health in low and middle-income
countries: an assessment using the case of Uganda’s responses to COVID-19 pandemic.
BMC Medical Ethics, 21(1), 91.
32. Bruce, L., & Tallman, R. (2021). Promoting racial equity in COVID-19 resource allocation.
Journal of Medical Ethics, 47(4), 208–212.
33. Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, Board on Health
Sciences Policy, Board on Population Health and Public Health Practice, Health and
Medicine Division, & National Academies of Sciences, Engineering, and Medicine. (2020).
Framework for Equitable Allocation of COVID-19 Vaccine (p. 25917; H. Gayle, W. Foege, L.
Brown, & B. Kahn, Eds.). Washington, D.C.: National Academies Press.
34. Emanuel, E. J., Luna, F., Schaefer, G. O., Tan, K.-C., & Wolff, J. (2021). Enhancing the WHO’s
Proposed Framework for Distributing COVID-19 Vaccines Among Countries. American
Journal of Public Health, 111(3), 371–373.
35. Emanuel, E. J., Persad, G., Kern, A., Buchanan, A., Fabre, C., Halliday, D., … Richardson, H. S.
(2020). An ethical framework for global vaccine allocation. Science, 369(6509), 1309–1312.
36. Hagan, K., Forman, R., Mossialos, E., Ndebele, P., Hyder, A. A., & Nasir, K. (2022). COVID19 vaccine mandate for healthcare workers in the United States: a social justice policy.
Expert Review of Vaccines, 21(1), 37–45.
37. Johnson, A. G., Amin, A. B., Ali, A. R., Hoots, B., Cadwell, B. L., Arora, S., … Scobie, H. M.
(2022). COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated
Adults with and Without Booster Doses During Periods of Delta and Omicron Variant
Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR. Morbidity and
Mortality Weekly Report, 71(4), 132–138.
38. Karaivanov, A., Kim, D., Lu, S. E., & Shigeoka, H. (2022). COVID-19 vaccination mandates
and vaccine uptake. Nature Human Behaviour, 6(12), 1615–1624.
39. Laar, A., DeBruin, D., Ofori-Asenso, R., Laar, M. E., Redman, B., & Caplan, A. (2021). Rationing
health and social goods during pandemics: Guidance for Ghanaian decision makers. Clinical
Ethics, 16(3), 165–170.
40. Laurencin, C. T. (2021). Addressing Justified Vaccine Hesitancy in the Black Community.
Journal of Racial and Ethnic Health Disparities, 8(3), 543–546.
41. Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., … Rodés-Guirao, L.
(2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), 947–
953.
42. Mathieu, E., Ritchie, H., Rodés-Guirao, L., Appel, C., Giattino, C., Hasell, J., … Roser, M.
(2020). Coronavirus Pandemic (COVID-19). Our World in Data. Retrieved from
https://ourworldindata.org/covid-vaccinations
43. Mello, M. M., Silverman, R. D., & Omer, S. B. (2020). Ensuring Uptake of Vaccines against
SARS-CoV-2. New England Journal of Medicine, 383(14), 1296–1299.
44. Morens, D. M., Folkers, G. K., & Fauci, A. S. (2022). The Concept of Classical Herd Immunity
May Not Apply to COVID-19. The Journal of Infectious Diseases, 226(2), 195–198.
45. National Academies of Sciences, E., Division, Health and Medicine, Practice, Board on
Population Health and Public Health, Policy, B. on H. S., Coronavirus, C. on E. A. of V. for the
N., Kahn, B., … Gayle, H. (2020). Lessons Learned from Other Allocation Efforts. National
Academies Press (US).
46. Pilz, S., Theiler-Schwetz, V., Trummer, C., Krause, R., & Ioannidis, J. P. A. (2022). SARS-CoV2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.
Environmental Research, 209, 112911.
47. Prugger, C., Spelsberg, A., Keil, U., Erviti, J., & Doshi, P. (2021). Evaluating covid-19 vaccine
efficacy and safety in the post-authorisation phase. BMJ, e067570.
48. Rubin, R. (2021). COVID-19 Vaccines vs Variants—Determining How Much Immunity Is
Enough. JAMA, 325(13), 1241.
49. Scharff, D. P., Mathews, K. J., Jackson, P., Hoffsuemmer, J., Martin, E., & Edwards, D. (2010).
More than Tuskegee: Understanding Mistrust about Research Participation. Journal of
Health Care for the Poor and Underserved, 21(3), 879–897.
50. SeyedAlinaghi, S., Mirzapour, P., Dadras, O., Pashaei, Z., Karimi, A., MohsseniPour, M., …
Shayesteh Jahanfar. (2021). Characterization of SARS-CoV-2 different variants and related
morbidity and mortality: a systematic review. European Journal of Medical Research, 26(1),
51.
51. Sina-Odunsi, A. J. (2021). COVID-19 vaccines inequity and hesitancy among African
Americans. Clinical Epidemiology and Global Health, 12, 100876.
52. Vasquez Reyes, M. (2020). The Disproportional Impact of COVID-19 on African Americans.
Health and Human Rights, 22(2), 299–307.
53. WHO. (2022). Global COVID-19 Vaccination Strategy in a Changing World: July 2022
update. https://www.who.int/publications/m/item/global-covid-19-vaccinationstrategy-in-a-changing-world–july-2022-update. Retrieved from
54. WHO Ethics and COVID-19 Working Group. (2021). COVID-19 and mandatory vaccination:
Ethical considerations. https://www.who.int/publications-detail-redirect/WHO-2019-
nCoV-Policy-brief-Mandatory-vaccination-2022.1. Retrieved from
55. Wong, R. S. Y. (2021). COVID-19 vaccines and herd immunity: Perspectives, challenges and
prospects. The Malaysian Journal of Pathology, 43(2), 203–217.
56. Wynia, M. K., Harter, T. D., & Eberl, J. T. (n.d.). Why A Universal COVID-19 Vaccine Mandate
Is Ethical Today. Health Affairs Forefront. Retrieved from
https://www.healthaffairs.org/do/10.1377/forefront.20211029.682797/full/.